Acorda Therapeutics reported $11K in Ordinary Share Capital for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ordinary Share Capital Change
Acadia Pharmaceuticals ACAD:US $ 0.02M 0M
Agios Pharmaceuticals AGIO:US $ 0.07M 0M
Alexion Pharmaceuticals ALXN:US $ 0M 0M
ALKERMES ALKS:US $ 1.65M 0M
Amgen AMGN:US $ 31989M 112M
Anika Therapeutics ANIK:US $ 0.14M 0M
Aptinyx Inc APTX:US $ 677K 0
Biogen BIIB:US $ 0.1M 0M
Biomarin Pharmaceutical BMRN:US $ 0.18M 0M
Cara Therapeutics CARA:US $ 50K 0
Clovis Oncology CLVS:US $ 0.13M 0.01M
Cytokinetics CYTK:US $ 0.08M 0.01M
GlaxoSmithKline GSK:LN 1347M 0M
Gw Pharmaceuticals GWPH:US $ 0.58M 0.01M
Halozyme Therapeutics HALO:US $ 0.14M 0M
Heron Therapeutics HRTX:US $ 1.02M 0M
Insmed INSM:US $ 1.18M 32K
Ligand Pharmaceuticals LGND:US $ 0.02M 0M
Mannkind MNKD:US $ 2.5M 0.01M
Merck MRK:GR € 168M 0M
Moderna Inc MRNA:US 40.5K 40.5K
Neurocrine Biosciences NBIX:US $ 0.1M 0M
Novartis NOVN:VX SF 901M 12M
Teva Pharmaceutical TEVA:IT 57M 0
Ultragenyx Pharmaceutical RARE:US $ 0.07M 0M
Vertex Pharmaceuticals VRTX:US $ 2.56M 0.03M